Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Arlt, V. M.
Right arrow Articles by Phillips, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arlt, V. M.
Right arrow Articles by Phillips, D. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis vol. 19 no. 2 pp. 149-156, March 2004
© 2004 UK Environmental Mutagen Society/Oxford University Press

Activation of 3-nitrobenzanthrone and its metabolites to DNA-damaging species in human B lymphoblastoid MCL-5 cells

Volker M. Arlt1, Kathleen J. Cole and David H. Phillips

Section of Molecular Carcinogenesis, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK

3-Nitrobenzanthrone (3-NBA) is one of the most potent mutagens in the Ames Salmonella typhimurium assay and a suspected human carcinogen recently identified in diesel exhaust and in airborne particulate matter. 3-Aminobenzanthrone (3-ABA), 3-acetylaminobenzanthrone (3-Ac-ABA) and N-acetyl-N-hydroxy-3-aminobenzanthrone (N-Ac-N-OH-ABA) have been identified as 3-NBA metabolites. In the present study we investigated the genotoxic effects of 3-NBA and its metabolites in the human B lymphoblastoid cell line MCL-5. DNA strand breaks were measured using the Comet assay, chromosomal damage was assessed using the micronucleus assay and DNA adduct formation was determined by 32P-post-labelling analysis. DNA strand-breaking activity was observed with each compound in a concentration-dependent manner (1–50 µM, 2 h incubation time). At 50 µM median comet tail lengths (CTLs) were 25.0 µm for 3-NBA, 48.0 µm for 3-ABA, 54.5 µm for 3-Ac-ABA and 65.0 µm for N-Ac-N-OH-ABA. Median CTLs in control incubations were in the range 7.7–13.1 µm. Moreover, the strand-breaking activity of 3-NBA was more pronounced in the presence of a DNA repair inhibitor, hydroxyurea. Depending on the concentration used (1–20 µM, 24 h incubation time), 3-NBA and its metabolites also showed clastogenic activity in the micronucleus assay. 3-NBA and N-Ac-N-OH-ABA were the most active at low concentrations; at 1 µM the total number of micronuclei per 500 binucleate cells was 4.7 ± 0.6 in both cases, compared with 1.7–3.0 for controls (P < 0.05). Furthermore, multiple DNA adducts were detected with each compound (1 µM, 24 h incubation time), essentially similar to those found recently in vivo in rats treated with 3-NBA or its metabolites. DNA adduct levels ranged from 1.3 to 42.8 and from 2.0 to 39.8 adducts/108 nt using the nuclease P1 and butanol enrichment procedures, respectively. DNA binding was highest for N-Ac-N-OH-ABA, followed by 3-NBA, and much lower for 3-ABA and 3-Ac-ABA. All major 3-NBA-derived DNA adducts produced in MCL-5 cells were found to be formed from reductive metabolites bound to purine bases and lacked an N-acetyl group. These results demonstrate that 3-NBA and its metabolites are effectively activated to DNA-damaging species in human MCL-5 cells, which may reflect the genotoxic potential of 3-NBA in humans. Environmental exposure to 3-NBA may be a health hazard for large sections of the population and the risks associated with such exposure require further assessment.

1To whom correspondence should be addressed. Tel: +44 20 8722 4405; Fax: +44 20 8722 4052; Email: volker.arlt{at}icr.ac.uk

Received on August 25, 2003; accepted on November 17, 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
E. Nagy, M. G. Cornelius, and L. Moller
Accelerated 32P-HPLC for bulky DNA adducts
Mutagenesis, March 1, 2009; 24(2): 183 - 189.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
V. M. Arlt, J. Gingerich, H. H. Schmeiser, D. H. Phillips, G. R. Douglas, and P. A. White
Genotoxicity of 3-nitrobenzanthrone and 3-aminobenzanthrone in MutaTMMouse and lung epithelial cells derived from MutaTMMouse
Mutagenesis, November 1, 2008; 23(6): 483 - 490.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. A. Bieler, M. G. Cornelius, M. Stiborova, V. M. Arlt, M. Wiessler, D. H. Phillips, and H. H. Schmeiser
Formation and persistence of DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation in rats
Carcinogenesis, May 1, 2007; 28(5): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Stiborova, H. Dracinska, J. Hajkova, P. Kaderabkova, E. Frei, H. H. Schmeiser, P. Soucek, D. H. Phillips, and V. M. Arlt
THE ENVIRONMENTAL POLLUTANT AND CARCINOGEN 3-NITROBENZANTHRONE AND ITS HUMAN METABOLITE 3-AMINOBENZANTHRONE ARE POTENT INDUCERS OF RAT HEPATIC CYTOCHROMES P450 1A1 AND -1A2 AND NAD(P)H:QUINONE OXIDOREDUCTASE
Drug Metab. Dispos., August 1, 2006; 34(8): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
V. M. Arlt
3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence
Mutagenesis, November 1, 2005; 20(6): 399 - 410.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. M. Arlt, M. Stiborova, C. J. Henderson, M. R. Osborne, C. A. Bieler, E. Frei, V. Martinek, B. Sopko, C. R. Wolf, H. H. Schmeiser, et al.
Environmental Pollutant and Potent Mutagen 3-Nitrobenzanthrone Forms DNA Adducts after Reduction by NAD(P)H:Quinone Oxidoreductase and Conjugation by Acetyltransferases and Sulfotransferases in Human Hepatic Cytosols
Cancer Res., April 1, 2005; 65(7): 2644 - 2652.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.